Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
13.15B | 13.71B | 15.69B | 16.34B | 16.09B | Gross Profit |
3.17B | 4.06B | 5.95B | 7.41B | 7.23B | EBIT |
1.42B | 2.29B | 4.27B | 5.75B | 5.62B | EBITDA |
3.00B | 3.86B | 5.91B | 7.73B | 7.58B | Net Income Common Stockholders |
1.79B | 5.12B | 3.26B | 3.11B | 4.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
29.55B | 39.33B | 31.65B | 33.53B | 32.20B | Total Assets |
114.90B | 118.55B | 116.33B | 112.93B | 112.59B | Total Debt |
1.12B | 1.53B | 2.01B | 2.35B | 2.86B | Net Debt |
-28.36B | -37.80B | -29.64B | -31.18B | -29.34B | Total Liabilities |
14.07B | 15.73B | 15.93B | 17.78B | 18.82B | Stockholders Equity |
100.23B | 102.23B | 99.84B | 94.56B | 93.11B |
Cash Flow | Free Cash Flow | |||
0.00 | 1.56B | -746.00M | 2.88B | 1.96B | Operating Cash Flow |
0.00 | 2.81B | 921.00M | 5.14B | 3.72B | Investing Cash Flow |
0.00 | 7.23B | -1.51B | -2.29B | -1.46B | Financing Cash Flow |
0.00 | -2.36B | -1.29B | -1.52B | -2.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $565.58B | 8.24 | 12.90% | 4.29% | 26.88% | 75.98% | |
74 Outperform | $3.84T | 15.50 | 7.82% | 2.17% | 10.16% | 11.31% | |
72 Outperform | ¥2.81T | 14.66 | 8.93% | 1.18% | 4.81% | 8.37% | |
71 Outperform | $3.39T | 18.28 | 7.53% | 1.59% | 4.99% | 14.16% | |
65 Neutral | €63.64B | 35.23 | 1.75% | 1.47% | -6.61% | -93.44% | |
63 Neutral | €164.18B | 15.77 | 7.84% | 3.45% | -5.31% | 19.66% | |
61 Neutral | $2.83B | 10.89 | 0.42% | 9.23% | 5.94% | -21.26% |